[A new antidepressive agent: C 34,276-Ba or maprotyline, 1st tetracyclic thymoanaleptic. Clinical study].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000639:Amitriptyline / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use; D000873:Anthracenes / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008744:Methylamines / Q000378:metabolism; D008875:Middle Aged; D010919:Placebos; D011437:Propylamines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D012098:Reproduction / Q000187:drug effects
D000873:Anthracenes; D000928:Antidepressive Agents; D008744:Methylamines; D010919:Placebos; D011437:Propylamines; D000639:Amitriptyline
Un nuevo antidepresive: el C 34,276-Ba o maprotilina, primer timoanaléptico tetracíclico. Investigación clíncia.